Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
Author(s) -
Eleftherios Pelechas,
Vassiliki Drossou,
Paraskevi V. Voulgari,
Alexandros A. Drosos
Publication year - 2022
Publication title -
mediterranean journal of rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2529-198X
DOI - 10.31138/mjr.33.1.68
Subject(s) - rheumatoid arthritis , medicine , immunology , tumor necrosis factor alpha , immune dysregulation , immune system , disease , chemokine , covid-19 , arthritis , rheumatology , autoimmune disease , rheumatoid factor , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom